Literature DB >> 7505016

The inhibition of different T cell lines specific for the same antigen with TCR antagonist peptides.

K Snoke1, J Alexander, A Franco, L Smith, J V Brawley, P Concannon, H M Grey, A Sette, P Wentworth.   

Abstract

To further understand and evaluate the phenomenon of TCR antagonism, we wished to determine whether analogs of an antigenic determinant could antagonize a specific polyclonal response. To this end, the ability of TCR antagonist peptides to inhibit a panel of five different DR4w4-restricted, influenza hemagglutinin 307-319-specific T cell lines was examined. An analysis of their V beta and J beta usage indicated that each of these five T cell lines expressed different TCR. A series of HA 307-319 single amino acid substituted analogs were used to determine the fine Ag specificities of the different lines. Ag analogs that demonstrated little or no stimulatory capacity were then examined for their ability to act as TCR antagonists by inhibiting the proliferative response of these five lines. Overall, 17 different peptide analogs capable of antagonizing at least one T cell line were identified. Although no single analog was capable of inhibiting all five T cell lines, two different analogs were identified that were capable of inhibiting four of five of the T cell specificities examined.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7505016

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Structure of a covalently stabilized complex of a human alphabeta T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1.

Authors:  J Hennecke; A Carfi; D C Wiley
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

2.  Development of a strategy and computational application to select candidate protein analogues with reduced HLA binding and immunogenicity.

Authors:  Sandeep Kumar Dhanda; Alba Grifoni; John Pham; Kerrie Vaughan; John Sidney; Bjoern Peters; Alessandro Sette
Journal:  Immunology       Date:  2017-09-28       Impact factor: 7.397

3.  Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis.

Authors:  R Bertoni; J Sidney; P Fowler; R W Chesnut; F V Chisari; A Sette
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

Review 4.  Immunological self/nonself discrimination: integration of self vs nonself during cognate T cell interactions with antigen-presenting cells.

Authors:  M D Mannie
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

5.  Partial signaling by CD8+ T cells in response to antagonist ligands.

Authors:  C Reis e Sousa; E H Levine; R N Germain
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

6.  In vivo antagonism of a T cell response by an endogenously expressed ligand.

Authors:  D Basu; C B Williams; P M Allen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

7.  Preferential usage of the T-cell receptor by influenza virus hemagglutinin-specific human CD4+ T lymphocytes: in vitro life span of clonotypic T cells.

Authors:  A Prévost-Blondel; D Chassin; D Zeliszewski; I Dorval; G Sterkers; C Pannetier; J G Guillet
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

8.  Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity.

Authors:  Jens Hennecke; Don C Wiley
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.